BackgroundCheck.run
Search For

Dan D Shochat, 851226 N 22Nd St, Boise, ID 83702

Known as:
Daniel Shochat Dan D Schochat Dan Shockey Dan R Daniel R
Related to:
Shari L Bennion 71

Dan Shochat Phones & Addresses

1226 N 22Nd St, Boise, ID 83702    650-3275304   

1590 Walnut Dr, Palo Alto, CA 94303    650-3275304    650-3275344    650-3275060   

15550 Bridgeview Dr, Anchorage, AK 99516   

Maplewood, NJ   

Cadiz, CA   

Lexington, KY   

1590 Walnut Dr, Palo Alto, CA 94303    650-8670853   

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Emails

d***[email protected]
Get Report
Control this profile

Mentions for Dan D Shochat

Dan Shochat resumes & CV records

Resumes

Dan Shochat Photo 10

President

Location:
Palo Alto, CA
Industry:
Pharmaceuticals
Work:
Kalobios Pharmaceuticals Jan 2004 - Jan 2013
Vp, Head of Non-Clinical Development Celscia Pharmaceuticals Mar 2003 - Jan 2004
Co-Founder and Chief Technology Officer Deltagen 2001 - 2002
Vp, Pharmaceutical Development Agama 2001 - 2002
President Coulter Pharmaceuticals 1995 - 2000
Senior Vice President and Chief Strategy Officer Nordion 1995 - 2000
Client American Cyanamid 1988 - 1995
Director, Biotechnology Development Rutgers University 1988 - 1992
Adjuct Professor Immunomedics 1984 - 1988
Direcor, R and D Group Center of Molecular Medicine & Immunology 1982 - 1983
Associate Member
Education:
Lsu Medical Center
Doctorates, Doctor of Philosophy, Biochemistry, Chemistry The Hebrew University of Jerusalem
Bachelors, Bachelor of Science, Zoology, Physiology The Hebrew University of Jerusalem
Master of Science, Masters, Biochemistry, Physiology
Skills:
Drug Development, Protein Chemistry, Glp, Cro, Life Sciences, Antibodies, Validation, Vaccines, Ind, Monoclonal Antibodies, Infectious Diseases, Sop, Regulatory Submissions, Cell Biology, Biotechnology, Cro Management, Technology Transfer, Biopharmacuticals R&D and Manufacturing, Antibody Drug Conjugates, Radiopharmacueticals, Gcp, Good Laboratory Practice, Pharmaceutical Industry, Prodrugs, Biomarkers, Standard Operating Procedure, Good Clinical Practice
Dan Shochat Photo 11

Vp, Head Of Non-Clinical Development At Kalobios Pharmaceuticals, Inc

Location:
San Francisco Bay Area
Industry:
Biotechnology

Publications & IP owners

Us Patents

Radioprotectant For Peptides Labeled With Radioisotope

US Patent:
6338835, Jan 15, 2002
Filed:
Dec 2, 1999
Appl. No.:
09/453985
Inventors:
Dan Shochat - Palo Alto CA
Albert S. K. Chan - Ottawa, CA
Michael J. Buckley - Pleasanton CA
David Colcher - San Mateo CA
Assignee:
Coulter Pharmaceutical, Inc. - South San Francisco CA
International Classification:
A61K 5100
US Classification:
424 169, 424 111, 424 165
Abstract:
A method of ameliorating degradation radiolabeled peptides, especially radiolabeled proteins such as antibodies, by including povidone, also widely known as polyvinylpyrrolidone or PVP, as a radioprotectant in a composition containing a radiolabeled peptide is described. A radioprotectant composition and a stable peptide-radioisotope composition having povidone are also described. Ascorbic acid or other secondary stabilizers may also be added to the compositions to further enhance radioprotection.

Non-Enzymatic Immunohistochemical Staining System And Reagents

US Patent:
4792521, Dec 20, 1988
Filed:
Aug 15, 1985
Appl. No.:
6/766106
Inventors:
Dan Shochat - Maplewood NJ
Assignee:
Immunomedics, Inc. - Newark NJ
International Classification:
G01N 3353
US Classification:
435 7
Abstract:
A non-enzymatic method of immunohistochemical staining uses a bound electron transfer agent to achieve amplification of antibody binding to specific antigens of interest in a histology or cytology specimen. A preferred embodiment uses a bound phenazine, which is reduced with a soluble reducing agent, and which in turn reduces a tetrazolium salt, to precipitate a formazan dye at the site of primary antibody binding to the antigen of interest. Reagents and kits for use in the method are also provided.

Radioprotectant For Peptides Labeled With Radioisotope

US Patent:
5961955, Oct 5, 1999
Filed:
Aug 21, 1997
Appl. No.:
8/918525
Inventors:
Dan Shochat - Palo Alto CA
Albert S. K. Chan - Ottawa, CA
Michael J. Buckley - Pleasanton CA
David Colcher - Omaha NE
Assignee:
Coulter Pharmaceutical, Inc. - South San Francisco CA
International Classification:
A61K 5100
A61K 3800
A01N 3718
C07K 200
US Classification:
424 169
Abstract:
A method of ameliorating degradation of radiolabeled peptides, especially radiolabeled proteins such as antibodies, by including povidone, also widely known as polyvinylpyrrolidone or PVP, as a radioprotectant in a composition containing a radiolabeled peptide is described. A radioprotectant composition and a stable peptide-radioisotope composition having povidone are also described. Ascorbic acid or other secondary stabilizers may also be added to the compositions to further enhance radioprotection.

Method For Radiolabeling Antibody Fragments

US Patent:
5514363, May 7, 1996
Filed:
Jan 7, 1993
Appl. No.:
8/001419
Inventors:
Dan Shochat - Maplewood NJ
Hans J. Hansen - Westfield NJ
Robert S. Wu - West Orange NJ
Assignee:
Immunomedics, Inc. - Morris Plains NJ
International Classification:
A61K 39395
US Classification:
424 149
Abstract:
A protein containing at least one pendant sulfhydryl group is directly radiolabeled with a radiometal which binds tightly to sulfhydryl groups, using one or more pendant sulfhydryl groups on the protein as endogenous ligands and optionally using an exogenous ligand which binds tightly to the radiometal ion to further stabilize the chelate.

Method For Radiolabeling Proteins

US Patent:
5061641, Oct 29, 1991
Filed:
Apr 1, 1988
Appl. No.:
7/176421
Inventors:
Dan Shochat - Maplewood NJ
Hans J. Hansen - Westfield NJ
Robert S. Wu - West Orange NJ
Assignee:
Immunomedics, Inc. - Warren NJ
International Classification:
G01N 33534
C07K 300
C07K 1500
A61K 4300
US Classification:
436545
Abstract:
A protein containing at least one pendant sulfhydryl group is directly radiolabeled with a radiometal which binds tightly to sulfhydryl groups, using one or more pendant sulfhydral groups on the protein as endogenous ligands and optionally using an exogenous ligand which binds tightly to the radiometal ion to further stabilize the chelate.

Public records

Vehicle Records

Dan Shochat

Address:
1590 Walnut Dr, Palo Alto, CA 94303
VIN:
3VWPL7AJ1AM669184
Make:
VOLKSWAGEN
Model:
JETTA
Year:
2010

Possible Relatives

David R Shochat  Dan Johnson  Dan W Stanaway  Dan L Johnston  Dan J Standridge  Dan E White  Dan M Jolly  Dan Jones  Dan Stanger  Dan E Stanley 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.